Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors

Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors

US Patent 10344031 · Granted Jul 9, 2019

Estimated economic value: $6,957,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists2018
Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (T2017
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (T2017
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (T2017
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (T2017